{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:52:58Z","timestamp":1781535178299,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-026-04474-3","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:24:16Z","timestamp":1777357456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term effects of ospemifene on densitometric and bone metabolism biomarkers in postmenopausal women reporting Vulvar and Vaginal Atrophy (VVA)"],"prefix":"10.1186","volume":"26","author":[{"given":"Silvia","family":"Maffei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Formica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"4474_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fendo.2019.00561","volume":"10","author":"RE Nappi","year":"2019","unstructured":"Nappi RE, Martini E, Cucinella L, Martella S, Tiranini L, Inzoli A, Brambilla E, Bosoni D, Cassani C, Gardella B. Addressing Vulvovaginal Atrophy (VVA)\/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women. Front Endocrinol. 2019;10:561.","journal-title":"Front Endocrinol"},{"key":"4474_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/0378-5122(95)00956-6","volume":"22","author":"G Bachmann","year":"1995","unstructured":"Bachmann G. Urogenital ageing: An old problem newly recognized. Maturitas. 1995;22:S1\u20135.","journal-title":"Maturitas"},{"key":"4474_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jbmr.534","volume":"27","author":"GA Greendale","year":"2011","unstructured":"Greendale GA, Sowers M, Han W, Huang MH, Finkelstein JS, Crandall CJ, Lee JS, Karlamangla AS. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: Results from the Study of Women\u2019s Health Across the Nation (SWAN). J Bone Min Res. 2011;27:111\u20138.","journal-title":"J Bone Min Res"},{"key":"4474_CR4","doi-asserted-by":"publisher","first-page":"E654","DOI":"10.1210\/jc.2012-3651","volume":"98","author":"CJ Crandall","year":"2013","unstructured":"Crandall CJ, Tseng CH, Karlamangla AS, Finkelstein JS, Randolph JF, Thurston RC, Huang MH, Zheng H, Greendale GA. Serum sex steroid levels and longitudinal changes in bone density in relation to the final menstrual period. J Clin Endocrinol Metab. 2013;98:E654\u201363.","journal-title":"J Clin Endocrinol Metab"},{"key":"4474_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/jbmr.4444","volume":"37","author":"A Moilanen","year":"2022","unstructured":"Moilanen A, Juho Kopra J, Kr\u00f6ger H, Sund R, Rikkonen T, Sirola J. Characteristics of Long-Term Femoral Neck Bone Loss in Postmenopausal Women: A 25-Year Follow-Up. J Bone Min Res. 2022;37:173\u20138.","journal-title":"J Bone Min Res"},{"key":"4474_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/8756-3282(96)00102-0","volume":"19","author":"BJ Riis","year":"1996","unstructured":"Riis BJ, Hansen MA, Jensen A, Overgaard K, Christiansen C. Low bone mass and fast rate of bone loss at menopause: Equal risk factors for future fracture: A 15-year follow-up study. Bone. 1996;19:9\u201312.","journal-title":"Bone"},{"key":"4474_CR7","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/S0378-5122(99)00064-X","volume":"33","author":"JC Gallagher","year":"1999","unstructured":"Gallagher JC. Moderation of the daily dose of HRT: Prevention of osteoporosis. Maturitas. 1999;33:S57\u201363.","journal-title":"Maturitas"},{"key":"4474_CR8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/gme.0b013e3181c1ac01","volume":"17","author":"GA Bachmann","year":"2010","unstructured":"Bachmann GA, Komi JO, Ospemifene Study Group. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: Results from a pivotal phase 3 study. Menopause. 2010;17:480\u201390.","journal-title":"Menopause"},{"key":"4474_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2147\/IJWH.S110035","volume":"8","author":"S Palacios","year":"2016","unstructured":"Palacios S, Cancelo MJ. Clinical update on the use of Ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy. Int J Womens Health. 2016;8:617\u201326.","journal-title":"Int J Womens Health"},{"key":"4474_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.steroids.2014.07.012","volume":"90","author":"MW DeGregorio","year":"2014","unstructured":"DeGregorio MW, Zerbe RL, Wurz GT, Ospemifene. A first-in-class, non-hormonal selective estrogen receptor modulator approved for the treatment of dyspareunia associated with vulvar and vaginal atrophy. Steroids. 2014;90:82\u201393.","journal-title":"Steroids"},{"key":"4474_CR11","unstructured":"European Public Assessment Report European Medicines Agency. 2014. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/smopinitial\/chmp-summary-positive-opinion-senshio_en.pdf. (accessed on 20 October 2022)."},{"key":"4474_CR12","unstructured":"European Medicines Agency. Senshio Public Assessment Report (03\/2022) Annex I Summary of Product Characteristics. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/senshio#assessment-history-section. (accessed on 20 Oct 2022)."},{"key":"4474_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17303\/jwhg.2021.8.301","volume":"8","author":"S Maffei","year":"2021","unstructured":"Maffei S, Papa A, di Cecco P, Guiducci L. Effect of Ospemifene on Cardiometabolic Risk in Postmenopausal Women Reporting Vulvo and Vaginal Atrophy (VVA): Results of a 12-Month Prospective Study. J Women\u2019s Health Gynecol. 2021;8:1\u201312.","journal-title":"J Women\u2019s Health Gynecol"},{"key":"4474_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3109\/13697137.2013.834493","volume":"17","author":"SR Goldstein","year":"2014","unstructured":"Goldstein SR, Bachmann GA, Koninckx PR, Lin VH, Portman DJ, Ylikorkala O, Ospemifene Study Group. Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy. Climacteric. 2014;17:173\u201382.","journal-title":"Climacteric"},{"key":"4474_CR15","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/GME.0000000000000619","volume":"23","author":"GD Constantine","year":"2016","unstructured":"Constantine GD, Kagan R, Miller PD. Effects of Ospemifene on bone parameters including clinical biomarkers in postmenopausal women. Menopause. 2016;23:638\u201344.","journal-title":"Menopause"},{"key":"4474_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/09513590410001672197","volume":"18","author":"J Komi","year":"2004","unstructured":"Komi J, Heikkinen J, Rutanen M, Halonen K, Lammintausta R, Ylikorkala O. Effects of Ospemifene, a novel SERM, on biochemical markers of bone turnover in healthy postmenopausal women. Gynecol Endocrinol. 2004;18:152\u20138.","journal-title":"Gynecol Endocrinol"},{"key":"4474_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s00774-006-0689-9","volume":"24","author":"J Komi","year":"2006","unstructured":"Komi J, Lankinen KS, DeGregorio M, Heikkinen J, Saarikoski S, Tuppurainen M, Halonen K, Lammintausta R, V\u00e4\u00e4n\u00e4nen K, Ylikorkala O, et al. Effects of Ospemifene and Raloxifene on biochemical markers of bone turnover in postmenopausal women. J Bone Min Metab. 2006;24:314\u20138.","journal-title":"J Bone Min Metab"},{"key":"4474_CR18","doi-asserted-by":"publisher","first-page":"6316","DOI":"10.3390\/jcm11216316","volume":"11","author":"S Maffei","year":"2022","unstructured":"Maffei S, Guiducci L. Effect of Ospemifene on Densitometric and Plasma Bone Metabolism Biomarkers in Postmenopausal Women Reporting Vulvar and Vaginal Atrophy (VVA). J Clin Med. 2022;11:6316.","journal-title":"J Clin Med"},{"key":"4474_CR19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/13697137.2019.1631789","volume":"22","author":"TJ de Villiers","year":"2019","unstructured":"de Villiers TJ, Altomare C, Particco M, Gambacciani M. Effects of Ospemifene on bone in postmenopausal women. Climacteric. 2019;22:442\u20137.","journal-title":"Climacteric"},{"key":"4474_CR20","doi-asserted-by":"publisher","unstructured":"Del Carmen Pingarr\u00f3n Santofimia M, Rodr\u00edguez SPG, Lilue M, Palacios S. Experience with ospemifene in patients with vulvar and vaginal atrophy: case studies with bone marker profiles. Drugs context 2020, 9, 2020\u20133. https:\/\/doi.org\/10.7573\/dic.2020-3-3.","DOI":"10.7573\/dic.2020-3-3"},{"issue":"11","key":"4474_CR21","doi-asserted-by":"publisher","first-page":"E912","DOI":"10.1152\/ajpendo.00488.2015","volume":"310","author":"AE B\u00f6rjesson","year":"2016","unstructured":"B\u00f6rjesson AE, Farman HH, Mov\u00e9rare-Skrtic S, Engdahl C, Antal MC, Koskela A, Tuukkanen J, Carlsten H, Krust A, Chambon P, Sj\u00f6gren K, Lagerquist MK, Windahl SH, Ohlsson C. SERMs have substance-specific effects on bone, and these effects are mediated via ER\u03b1AF-1 in female mice. Am J Physiol Endocrinol Metab. 2016;310(11):E912\u20138. https:\/\/doi.org\/10.1152\/ajpendo.00488.2015.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4474_CR22","doi-asserted-by":"publisher","unstructured":"Palacios S. Ospemifene for vulvar and vaginal atrophy: an overview. Drugs context. 2020. 9, 2020-3-2. https:\/\/doi.org\/10.7573\/dic.2020-3-2.","DOI":"10.7573\/dic.2020-3-2"},{"key":"4474_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1210\/endo.141.2.7342","volume":"141","author":"Q Qu","year":"2000","unstructured":"Qu Q, Zheng H, Dahllund J, Laine A, Cockcroft N, Peng Z, Koskinen M, Hemminki K, Kangas L, V\u00e4\u00e4n\u00e4nen K, et al. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats. Endocrinology. 2000;141:809\u201320.","journal-title":"Endocrinology"},{"key":"4474_CR24","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.steroids.2013.09.003","volume":"78","author":"L Kangas","year":"2013","unstructured":"Kangas L, Unkila M. Tissue selectivity of Ospemifene: Pharmacologic profile and clinical implications. Steroids. 2013;78:1273\u201380.","journal-title":"Steroids"},{"key":"4474_CR25","first-page":"1","volume":"843","author":"World Health Organization","year":"1994","unstructured":"World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Report of a WHO study group (meeting held in Rome from Jun 22\u201325, 1992). World Health Organ Tech Rep Ser. 1994;843:1\u2013129.","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"12","key":"4474_CR26","doi-asserted-by":"publisher","first-page":"e2188","DOI":"10.1210\/clinem\/dgae099","volume":"109","author":"SM Hussain","year":"2024","unstructured":"Hussain SM, Seeman E, Schneider HG, Ebeling PR, Barker AL, Polkinghorne K, Newman AB, Yu C, Lacaze P, Owen A, Tran C, Nelson MR, Woods RL, Yeap BB, ClarK D, Beilin LJ, McNeil JJ. Association of Serum Phosphate, Calcium and Alkaline Phosphatase With Risk of Incident Fractures in Healthy Older Adults. J Clin Endocrinol Metab. 2024;109(12):e2188\u201395. https:\/\/doi.org\/10.1210\/clinem\/dgae099.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"4474_CR27","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.3390\/nu14091738","volume":"14","author":"K Fulgoni","year":"2022","unstructured":"Fulgoni K, Fulgoni VL 3rd, Wallace TC. Association of Total, Added, and Natural Phosphorus Intakes with Biomarkers of Health Status and Mortality in Healthy Adults in the United States. Nutrients. 2022;14(9):1738. https:\/\/doi.org\/10.3390\/nu14091738.","journal-title":"Nutrients"},{"issue":"1","key":"4474_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/GME.0000000000000275","volume":"22","author":"GD Constantine","year":"2015","unstructured":"Constantine GD, Goldstein SR, Archer DF. Endometrial safety of ospemifene: results of the phase 2\/3 clinical development program. Menopause (New York N Y). 2015;22(1):36\u201343. https:\/\/doi.org\/10.1097\/GME.0000000000000275.","journal-title":"Menopause (New York N Y)"},{"key":"4474_CR29","doi-asserted-by":"publisher","unstructured":"Pennacchini E, Dall\u2019Alba R, Iapaolo S, Marinelli M, Palazzetti PL, Zullo MA, Cervigni M, Morciano A, Campanella L, Ferraresi B, Schiavi MC. Treatment of genitourinary syndrome of menopause in breast cancer and gynecologic cancer survivors: retrospective analysis of efficacy and safety of vaginal estriol, vaginal dehydroepiandrosterone and ospemifene. J Menopausal Med. 2024;30(3):170\u20138. https:\/\/doi.org\/10.6118\/jmm.24011.","DOI":"10.6118\/jmm.24011"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-026-04474-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04474-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04474-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:03:47Z","timestamp":1781532227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-026-04474-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4474"],"URL":"https:\/\/doi.org\/10.1186\/s12905-026-04474-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8584043\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study The study was conducted in accordance with the Declaration of Helsinki and was approved by the Local Ethics Committee of the Italian National Research Council\u2013Gabriele Monasterio Tuscan Foundation, Pisa, Italy (Protocol No. 37981, Study No. 3605, approved on 20 June 2012). Written informed consent was obtained from all participants at the baseline visit. The study was registered at ClinicalTrials.gov with the identification code NCT03699150.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"296"}}